GlassScriptPhysician profile
Robert J Roland
NPI 1588680458
$4,102.55
in general payments reported to CMS, 2019-2025
31 companies · $534 in 2025
The $534 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $253 · 2021: $522 · 2022: $989 · 2023: $744 · 2024: $634 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872 · Travel and Lodging: $39.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.79 |
| Travel and Lodging | $39.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $817.97 | 2019-2025 | Collagenase Santyl, Regranex, Renasys Go V2 Home |
| Musculoskeletal Transplant Foundation INC. | $687.44 | 2021-2025 | |
| Kerecis Limited | $291.93 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $284.23 | 2021-2025 | Dalvance |
| Organogenesis INC. | $272.87 | 2020-2025 | Apligraf, Puraply Wound Matrix, Puraply |
| Reapplix INC. | $247.09 | 2022-2023 | 3c Patch Kit - Box |
| Urgo Medical North America, LLC | $178.92 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Integra Lifesciences Corporation | $151.98 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $150.01 | 2022 | |
| Solventum Corporation | $103.92 | 2024-2025 | Activ.A.C., Prevena |
| Lifenet Health | $89.03 | 2025 | Theragenesis Wound Matrix |
| Polarityte, INC. | $87.34 | 2019-2020 | |
| Viiv Healthcare Company | $85.05 | 2019-2023 | Apretude |
| Intuitive Surgical, INC. | $77.35 | 2022 | |
| Next Science LLC | $69.46 | 2022-2023 | Xperience, Blastx, Surgx |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $51.95 | 2019-2020 | |
| Convatec INC. | $46.19 | 2024 | |
| Hydrofera LLC | $42.26 | 2024 | Hydrofera Blue |
| 3m Company | $42.15 | 2019 | |
| Innovation Technologies INC | $40.83 | 2021 | |
| Tactile Systems Technology INC | $38.88 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Bsn Medical INC | $33.78 | 2025 | |
| Progenacare Global, LLC | $29.70 | 2023 | |
| Paratek Pharmaceuticals, INC. | $28.53 | 2020 | |
| Celularity INC. | $27.00 | 2019 | |
| Aroa Biosurgery Incorporated | $26.65 | 2019 | |
| Fidia Pharma USA INC. | $23.97 | 2024 | |
| Molnlycke Health Care US, LLC | $21.45 | 2024 | Mepilex Border Sacrum, Mepilex Border Flex, Mepilex |
| Sanara Medtech INC. | $21.04 | 2025 | Celleraterx |
| Hollister Incorporated | $17.62 | 2021 | |
| Acera Surgical, INC. | $15.96 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Roland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.